I was referring to CGB actually...You know..The one with a current market cap of $134.3m according to HC.
Sounds like your referring to T12 which is now a CGB subsidiary that now incorporates the full suite of Vitahemp products..With T12 existing footprint/product range in Asia they are able to compliment each other very well.
Your also forgetting BioHealth..Pharmacann..Canntab..Medcann..Dr Meiri in Israel.
Plenty of fireworks to come.
And I know you value our bauxite highly..Great questions earlier by the way..Almost worthy of an actual phone call to the company or do you always try to communicate with $100m plus companies via Hot Copper? Each to their own I guess.
Just quietly..If you try to actually apply justifiable valuations against any companies assets, cash on hand, revenue, IP than you would never spend a dollar at this end of the market..Or the top end for that matter.
Happy trading
@nihilism ...May any good fortunes for you surrounding CGB continue.
